Teva Pharmaceutical Industries Limited Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Fi...
November 23 2016 - 9:58AM
Business Wire
Rosen Law Firm, a global investor rights law firm, reminds
purchasers of the American Depositary Shares (“ADSs”) of Teva
Pharmaceutical Industries Limited (NYSE:TEVA) between February 10,
2015 and November 3, 2016, both dates inclusive (the “Class
Period”) of the important January 5, 2017 lead plaintiff deadline
in the class action filed by the firm. The lawsuit seeks recovery
of investor losses. Investors with losses in excess of $1 million
are encouraged to contact the firm about the lead plaintiff
deadline.
To join the Teva class action, go to the website at
http://www.rosenlegal.com/cases-979.html or call Phillip Kim, Esq.
or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Teva was engaging and/or had engaged in conduct that
would result in an antitrust investigation by the U.S. Department
of Justice (“DOJ”) and the State of Connecticut Office of the
Attorney General; (2) the DOJ investigation and the underlying
conduct could cause U.S. prosecutors to file criminal charges
against Teva by the end of 2016 for suspected price collusion; (3)
in turn, Teva lacked effective internal controls over financial
reporting; and (4) as a result, Teva’s public statements were
materially false and misleading at all relevant times. Attorney
Advertising. Prior results do not guarantee a similar outcome.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
January 5, 2017. If you wish to join the litigation, go to:
http://www.rosenlegal.com/cases-979.html or to discuss your rights
or interests regarding this class action, please contact Phillip
Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or
via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161123005415/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: 212-686-1060Toll Free: 866-767-3653Fax:
212-202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Apr 2023 to Apr 2024